Showing results (1-10 of 525) with videos related to
Sort By:
Pageof 53
Frontiers in Immunology|September 11, 2023
CSF-1 and Notch signaling cooperate in macrophage instruction and tissue repair during peripheral limb ischemiaTamar Kapanadze, Jaba Gamrekelashvili, Stefan Sablotny, et al.Innere Medizin (Heidelberg, Germany)|November 3, 2022
[What is confirmed in the treatment of chronic kidney disease?]Robert Greite, Kai Schmidt-OttHerz|September 12, 2022
Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes : Lessons from the FIGARO-DKD trialHermann HallerMedizinische Klinik, Intensivmedizin Und Notfallmedizin|October 2, 2021
[Hypo- and hypernatremia in the intensive care unit : Pitfalls in volume management]Johannes Schilling, Friederike Compton, Kai Schmidt-OttHerz|September 2, 2004
[Diabetic nephropathy - current concepts in early diagnosis and treatment of diabetic microvascular complications]Matthias Meier, Hermann HallerSeminars in Hematology|July 17, 2007
Erythropoietin and treatment of non-anemic conditions--cardiovascular protectionDanilo Fliser, Hermann HallerDrugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Fixed-dose lercanidipine/enalapril for hypertensionJan Menne, Hermann HallerJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 22, 2003
The right diagnostic work-up: investigating renal and renovascular disordersJörg Radermacher, Hermann HallerAntioxidants (Basel, Switzerland)|November 27, 2021
Calcium Dobesilate Modulates PKCδ-NADPH Oxidase- MAPK-NF-κB Signaling Pathway to Reduce <i>CD14</i>, <i>TLR4</i>, and <i>MMP9</i> Expression during Monocyte-to-Macrophage Differentiation: Potential Therapeutic Implications for AtherosclerosisFlorence Njau, Hermann HallerNephron. Physiology|August 7, 2003
Participation of the mineralocorticoid receptor in cardiac and vascular remodelingAnette Fiebeler, Hermann HallerPageof 53